Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Long-Term Disease-Free Survival of Non-Metastatic Breast Cancer Patients in Iran: A Survival Model With Competing Risks Taking Cure Fraction and Frailty Into Account Publisher Pubmed



Ghavami V1 ; Mahmoudi M1 ; Foroushani AR1 ; Baghishani H2 ; Shandiz FH3 ; Yaseri M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Department of Applied Mathematics, Shahrood University of Technology, Shahrood, Iran
  3. 3. Cancer Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

Source: Asian Pacific Journal of Cancer Prevention Published:2017


Abstract

Introduction: Survival modeling is a very important tool to detect risk factors and provide a basis for health care planning. However, cancer data may have properties leading to distorted results with routine methods. Therefore, this study aimed to cover specific factors (competing risk, cure fraction and heterogeneity) with a real dataset of Iranian breast cancer patients using a competing risk-cure-frailty model. Materials and methods: For this historical cohort study, information for 550 Iranian breast cancer patients who underwent surgery for tumor removal from 2001 to 2007 and were followed up to March 2017, was analyzed using R 3.2 software. Results: In contrast to T-stage and N-stage, hormone receptor status did not have any significant effect on the cure fraction (long-term disease-free survival). However, T-stage, N-stage and hormone receptor status all had a significant effect on short-term disease-free survival so that the hazard of loco-regional relapse or distant metastasis in cases positive for a hormone receptor was only 0.3 times that for their negative hormone receptor counterparts. The likelihood of locoregional relapse in the first quartile of follow up was nearly twice that of other quartiles. The least cumulative incidence of time to locoregional relapse was for cases with a positive hormone receptor, low N stage and low T stage. The effect of frailty term was significant in this study and a model with frailty appeared more appropriate than a model without, based on the Akaike information criterion (AIC); values for the frailty model and one without the frailty parameter were 1370.39 and 1381.46, respectively. Conclusions: The data from this study indicate ae necessity to consider competing risk, cure fraction and heterogeneity in survival modeling. The competing risk-cure-frailty model can cover complex situations with survival data.
Related Docs
View other Related Docs
1. A Competing Risks Cure Frailty Model: An Application to Relapse-Free Survival of Breast Cancer Patients, Pakistan Journal of Statistics and Operation Research (2021)
2. Determination of a Change Point in the Age at Diagnosis of Breast Cancer Using a Survival Model, Asian Pacific Journal of Cancer Prevention (2016)
3. A Cause-Specific Hazard Spatial Frailty Model for Competing Risks Data, Spatial Statistics (2018)
4. Methods of Competing Risks Flexible Parametric Modeling for Estimation of the Risk of the First Disease Among Hiv Infected Men, BMC Medical Research Methodology (2020)
5. A Spatial Survival Model in Presence of Competing Risks for Iranian Gastrointestinal Cancer Patients, Asian Pacific Journal of Cancer Prevention (2018)
6. Epidemiology Characteristics and Trends of Lung Cancer Incidence in Iran, Asian Pacific Journal of Cancer Prevention (2016)
7. Detection of Merkel Cell Polyomavirus and Human Papillomavirus in Esophageal Squamous Cell Carcinomas and Non-Cancerous Esophageal Samples in Northern Iran, Pathology and Oncology Research (2016)
8. Gene Panel Testing in Hereditary Breast Cancer, Archives of Iranian Medicine (2020)
Experts (# of related papers)
View all Related Experts
Mehdi Yaseri (4)
Abbas Rahimi Foroushani (3)
Other Related Docs
9. Evaluation of Factors Related to Short-Term and Long-Term Survival of Breast Cancer Patients by Mixture Cure Model, Iranian Journal of Breast Diseases (2022)
10. Application of the Multiplicative-Additive Model in the Bone Marrow Transplantation Survival Data Including Competing Risks, Iranian Journal of Public Health (2015)
11. Plga-Methionine Labeled Bodipy Nano-Conjugate for In-Vivo Optical Tumor Imaging, Applied Nanoscience (Switzerland) (2020)
12. Use of Data-Mining to Support Real-World Cost Analyses: An Example Using Her2-Positive Breast Cancer in Iran, PLoS ONE (2018)
13. Is There a Stronger Graft-Versus-Leukemia Effect Using Hla-Haploidentical Donors Compared With Hla-Identical Siblings?, Leukemia (2016)
14. Comparable Outcomes of Pre- Versus Post-Tyrosine Kinase Inhibitor Era Treatment in Chronic Myeloid Leukemia: A Retrospective Cohort Study With Long-Term Follow-Up, Cell Transplantation (2023)
15. Diabetes Is Associated With Increased Liver Cancer Incidence and Mortality in Adults: A Report From Asia Cohort Consortium, International Journal of Cancer (2024)
16. Prediction of Local Recurrence After Oncoplastic Breast Surgery: Analysis of a Large Cohort, Journal of Surgical Research (2021)
17. The Trend in Histological Changes and the Incidence of Esophagus Cancer in Iran (2003–2008), International Journal of Preventive Medicine (2016)
18. Determining the Factors Correlated With Breast Cancer Recurrence Using the Poisson Beta-Weibull Non-Mixture Cure Model, Iranian Journal of Breast Diseases (2020)
19. Alterations of Vitamin D Receptor (Vdr) Expression Profile in Normal and Malignant Breast Tissues, Clinical Laboratory (2016)
20. Incidence and Trend of Liver Cancer in Iran, Journal of the College of Physicians and Surgeons Pakistan (2016)
21. Application of Canonical Correlation Analysis for Detecting Risk Factors Leading to Recurrence of Breast Cancer, Iranian Red Crescent Medical Journal (2016)
22. Effective Factors for Risk of Death in Patients With Cirrhosis Using Competing Risks Model, Govaresh (2016)
23. Survival Rates of Patients With Breast Cancer in Countries in the Eastern Mediterranean Region: A Systematic Review and Meta-Analysis; [Taux De Survie Des Patients Atteints De Cancer Du Sein Dans Les Pays De La Region De La Mediterranee Orientale: Analyse Systematique Et Meta-Analyse], Eastern Mediterranean Health Journal (2020)
24. A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies, Cancers (2022)
25. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends, Asian Pacific Journal of Cancer Prevention (2016)
26. Prognostic Cut Point for Breast Cancer Age of Diagnosis, International Journal of Cancer Management (2018)
27. A Comparison Between Accelerated Failure-Time and Cox Proportional Hazard Models in Analyzing the Survival of Gastric Cancer Patients, Iranian Journal of Public Health (2015)
28. Enhancing Breast Cancer Surgery Outcomes: A Comprehensive Review of Oncoplastic Techniques, Surgical Planning, and Aesthetic Considerations, Critical Reviews in Oncology/Hematology (2025)
29. How Do Donor-Recipient Cmv Serostatus and Post-Hematopoietic Stem Cell Transplantation Cmv Reactivation Affect Outcomes in Acute Leukemia Patients?, International Journal of Hematology-Oncology and Stem Cell Research (2017)